Literature DB >> 29497975

Plasma concentration of urokinase plasminogen activator receptor is a marker of kidney allograft function.

Marzena Staniszewska1, Violetta Dziedziejko2, Ewa Kwiatkowska3, Marta Tkacz1, Kamila Puchałowicz2, Krzysztof Safranow2, Leszek Domanski3, Andrzej Pawlik4.   

Abstract

BACKGROUND: Urokinase-type plasminogen activator receptor (uPAR) is found in a variety of cell types including monocytes, lymphocytes, macrophages, and endothelial cells and plays an important role in fibrinolysis and in the activation and chemotaxis of neutrophils and lymphocytes. In this study, we examined the correlation between uPAR plasma concentration and kidney allograft function. AIMS: This study enrolled 78 Caucasian deceased-donor renal transplant recipients.
METHODS: Plasma concentrations of uPAR were measured using commercially available enzyme-linked immunosorbent assay (ELISA) kits.
RESULTS: We observed elevated with borderline significance (p = 0.095) uPAR plasma concentrations in patients with tubular atrophy. Plasma concentrations of uPAR showed strong statistically significant positive correlations with serum creatinine or urea and strong negative correlation with estimated glomerular filtration rate (eGFR). There was also a borderline positive correlation between uPAR plasma concentration and protein concentration in urine as well as the duration of hemodialysis.
CONCLUSIONS: The results of our study indicate that uPAR plasma concentrations in kidney allograft recipients are significantly negatively correlated with graft function and may be elevated in patients with tubular atrophy.

Entities:  

Keywords:  Acute rejection; Delayed graft function; Renal transplantation; Urokinase-type plasminogen activator receptor (uPAR)

Mesh:

Substances:

Year:  2018        PMID: 29497975     DOI: 10.1007/s11845-018-1767-4

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  21 in total

1.  Soluble Urokinase Receptor and Chronic Kidney Disease.

Authors:  Marco Quaglia; Claudio Musetti; Vincenzo Cantaluppi
Journal:  N Engl J Med       Date:  2016-03-03       Impact factor: 91.245

2.  Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis.

Authors:  Changli Wei; Shafic El Hindi; Jing Li; Alessia Fornoni; Nelson Goes; Junichiro Sageshima; Dony Maiguel; S Ananth Karumanchi; Hui-Kim Yap; Moin Saleem; Qingyin Zhang; Boris Nikolic; Abanti Chaudhuri; Pirouz Daftarian; Eduardo Salido; Armando Torres; Moro Salifu; Minnie M Sarwal; Franz Schaefer; Christian Morath; Vedat Schwenger; Martin Zeier; Vineet Gupta; David Roth; Maria Pia Rastaldi; George Burke; Phillip Ruiz; Jochen Reiser
Journal:  Nat Med       Date:  2011-07-31       Impact factor: 53.440

3.  Urokinase plasminogen activator receptor and its soluble form in common biopsy-proven kidney diseases and in staging of diabetic nephropathy.

Authors:  Chung-Ze Wu; Li-Chien Chang; Yuh-Feng Lin; Yi-Jen Hung; Dee Pei; Nain-Feng Chu; Jin-Shuen Chen
Journal:  Clin Biochem       Date:  2015-07-08       Impact factor: 3.281

4.  Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates.

Authors:  Carlos R Franco Palacios; John C Lieske; Hani M Wadei; Andrew D Rule; Fernando C Fervenza; Nikolay Voskoboev; Vesna D Garovic; Ladan Zand; Mark D Stegall; Fernando G Cosio; Hatem Amer
Journal:  Transplantation       Date:  2013-08-27       Impact factor: 4.939

5.  Expression of urokinase plasminogen activator and its receptor during acute renal allograft rejection.

Authors:  Joris J T H Roelofs; Ajda T Rowshani; José G van den Berg; Nike Claessen; Jan Aten; Ineke J M ten Berge; Jan J Weening; Sandrine Florquin
Journal:  Kidney Int       Date:  2003-11       Impact factor: 10.612

6.  Soluble Urokinase Receptor and Chronic Kidney Disease.

Authors:  Salim S Hayek; Sanja Sever; Yi-An Ko; Howard Trachtman; Mosaab Awad; Shikha Wadhwani; Mehmet M Altintas; Changli Wei; Anna L Hotton; Audrey L French; Laurence S Sperling; Stamatios Lerakis; Arshed A Quyyumi; Jochen Reiser
Journal:  N Engl J Med       Date:  2015-11-05       Impact factor: 91.245

Review 7.  The urokinase receptor: focused cell surface proteolysis, cell adhesion and signaling.

Authors:  Francesco Blasi; Nicolai Sidenius
Journal:  FEBS Lett       Date:  2009-12-27       Impact factor: 4.124

8.  A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease.

Authors:  Joann M Spinale; Laura H Mariani; Shiv Kapoor; Jidong Zhang; Robert Weyant; Peter X Song; Hetty N Wong; Jonathan P Troost; Crystal A Gadegbeku; Debbie S Gipson; Matthias Kretzler; Deepak Nihalani; Lawrence B Holzman
Journal:  Kidney Int       Date:  2014-10-29       Impact factor: 10.612

9.  Full-length soluble urokinase plasminogen activator receptor down-modulates nephrin expression in podocytes.

Authors:  Massimo Alfano; Paola Cinque; Guido Giusti; Silvia Proietti; Manuela Nebuloni; Silvio Danese; Silvia D'Alessio; Marco Genua; Federica Portale; Manuela Lo Porto; Pravin C Singhal; Maria Pia Rastaldi; Moin A Saleem; Domenico Mavilio; Joanna Mikulak
Journal:  Sci Rep       Date:  2015-09-18       Impact factor: 4.379

10.  Urinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosis.

Authors:  Jing Huang; Gang Liu; Yi-miao Zhang; Zhao Cui; Fang Wang; Xiao-jing Liu; Rong Chu; Ming-hui Zhao
Journal:  BMC Med       Date:  2014-05-20       Impact factor: 8.775

View more
  1 in total

Review 1.  Coagulation and Fibrinolysis in Kidney Graft Rejection.

Authors:  Giovanni Stallone; Paola Pontrelli; Federica Rascio; Giuseppe Castellano; Loreto Gesualdo; Giuseppe Grandaliano
Journal:  Front Immunol       Date:  2020-08-25       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.